Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,023.04
53.89
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,635.83
0.07%
5.97

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.03
7.38
7.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.63
12.10
28.05

PAT CAGR (%)

10 Years
5 Years
3 Years

-3.20
-11.93
-

P:E (Median)

8 Years
5 Years
3 Years

38.90
72.40
61.94

P:BV (Average)

8 Years
5 Years
3 Years

2.52
2.50
2.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.40
24.19
24.29

Earnings Forecasts:

(Updated: 08-08-2026)

Description 2026 2027 2028 2029
Adj EPS 75 12 - -
P/E Ratio 10.93 68.31 - -
Revenue 44.84 32.3 - 1536.2
EBITDA 1800.27 2130.33 - 444.2
Net Income 541.47 677.83 - 218
ROA 262.17 364.4 - -
P/B Ratio - - - 6.20
ROE 4.08 3.64 - 8
FCFF 9.47 11.87 - -
FCFF Yield 30.02 117.65 - -
Net Debt 0.24 0.95 - -
BVPS - - - 132.2

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 189.04 93.46 102.27% 201.11 126.21 59.35% 165.70 125.39 32.15% 134.93 129.68 4.05%
Expenses 133.03 73.62 80.70% 141.32 88.19 60.24% 134.70 102.92 30.88% 95.79 86.88 10.26%
EBITDA 56.01 19.84 182.31% 59.79 38.02 57.26% 31.01 22.47 38.01% 39.14 42.80 -8.55%
EBIDTM 29.63% 21.23% 29.73% 30.12% 18.71% 17.92% 29.01% 33.00%
Other Income 9.56 13.02 -26.57% 6.89 10.64 -35.24% 11.29 16.26 -30.57% 16.94 20.85 -18.75%
Interest 2.53 2.23 13.45% 2.62 1.91 37.17% 2.74 1.19 130.25% 2.44 1.01 141.58%
Depreciation 15.49 13.06 18.61% 14.41 12.34 16.77% 13.56 12.20 11.15% 13.15 12.02 9.40%
PBT 51.06 12.39 312.11% 78.02 -9.91 - 23.79 24.86 -4.30% 38.92 50.15 -22.39%
Tax -13.86 -6.32 - 7.06 -4.28 - 7.85 9.21 -14.77% 8.10 20.16 -59.82%
PAT 64.92 18.71 246.98% 70.96 -5.63 - 15.93 15.65 1.79% 30.83 29.99 2.80%
PATM 34.34% 20.02% 35.28% -4.46% 9.62% 12.48% 22.85% 23.13%
EPS 3.32 0.96 245.83% 3.63 -0.29 - 0.81 0.80 1.25% 1.58 1.53 3.27%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 465.78 321.47 44.89% 436.99 330.82 32.09% 409.73 319.30 28.32% 369.97 343.80 7.61%
Expenses 329.52 229.84 43.37% 317.28 251.62 26.09% 295.43 238.66 23.79% 261.69 257.79 1.51%
EBITDA 136.26 91.63 48.71% 119.71 79.20 51.15% 114.30 80.65 41.72% 108.28 86.00 25.91%
EBIDTM 29.25% 28.50% 27.39% 23.94% 27.90% 25.26% 29.27% 25.02%
Other Income 3.13 6.38 -50.94% 1.67 7.63 -78.11% 0.81 1.18 -31.36% 1.75 4.99 -64.93%
Interest 12.10 18.78 -35.57% 13.66 14.49 -5.73% 10.68 11.75 -9.11% 15.67 25.55 -38.67%
Depreciation 35.20 28.92 21.72% 30.62 28.79 6.36% 30.36 28.81 5.38% 29.82 28.28 5.45%
PBT 92.09 50.31 83.05% 102.12 12.97 687.36% 61.21 41.27 48.32% 64.54 37.16 73.68%
Tax -2.83 2.70 - 12.65 0.76 1,564.47% 16.27 9.83 65.51% 20.36 18.83 8.13%
PAT 94.92 47.61 99.37% 89.47 12.21 632.76% 44.94 31.44 42.94% 44.18 18.33 141.03%
PATM 20.38% 14.81% 20.47% 3.69% 10.97% 9.85% 11.94% 5.33%
EPS 5.16 2.40 115.00% 5.51 0.74 644.59% 2.28 1.63 39.88% 2.25 0.92 144.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 690.78 477.34 309.79 247.70 356.95 257.05 805.97 663.88 741.29 733.67 675.79 Net Sales Growth 45.51% 54.09% 25.07% -30.61% 38.86% -68.11% 21.40% -10.44% 1.04% 8.56% Cost Of Goods Sold 247.71 111.07 79.41 73.26 67.61 50.87 258.38 229.62 348.45 365.75 359.49 Gross Profit 443.07 366.27 230.38 174.44 289.34 206.19 547.60 434.26 392.85 367.92 316.30 GP Margin 64.14% 76.73% 74.37% 70.42% 81.06% 80.21% 67.94% 65.41% 53.00% 50.15% 46.80% Total Expenditure 504.84 363.13 288.31 302.88 345.93 228.58 568.18 476.96 573.43 560.97 511.35 Power & Fuel Cost - 17.96 18.73 18.70 17.47 12.42 35.31 31.39 27.00 24.56 20.54 % Of Sales - 3.76% 6.05% 7.55% 4.89% 4.83% 4.38% 4.73% 3.64% 3.35% 3.04% Employee Cost - 99.61 103.64 109.54 110.57 76.10 149.28 124.66 113.29 91.53 67.27 % Of Sales - 20.87% 33.45% 44.22% 30.98% 29.61% 18.52% 18.78% 15.28% 12.48% 9.95% Manufacturing Exp. - 68.44 35.81 49.01 69.46 42.87 75.34 55.63 55.48 50.58 42.10 % Of Sales - 14.34% 11.56% 19.79% 19.46% 16.68% 9.35% 8.38% 7.48% 6.89% 6.23% General & Admin Exp. - 43.33 32.03 32.09 55.13 27.74 24.76 16.55 12.15 11.52 9.00 % Of Sales - 9.08% 10.34% 12.96% 15.44% 10.79% 3.07% 2.49% 1.64% 1.57% 1.33% Selling & Distn. Exp. - 12.36 7.07 6.15 15.59 10.25 10.04 6.51 6.00 4.51 7.24 % Of Sales - 2.59% 2.28% 2.48% 4.37% 3.99% 1.25% 0.98% 0.81% 0.61% 1.07% Miscellaneous Exp. - 10.35 11.63 14.13 10.09 8.33 15.07 12.61 11.06 12.52 7.24 % Of Sales - 2.17% 3.75% 5.70% 2.83% 3.24% 1.87% 1.90% 1.49% 1.71% 0.84% EBITDA 185.95 114.21 21.48 -55.18 11.02 28.47 237.79 186.92 167.86 172.70 164.44 EBITDA Margin 26.92% 23.93% 6.93% -22.28% 3.09% 11.08% 29.50% 28.16% 22.64% 23.54% 24.33% Other Income 44.68 94.22 93.94 79.82 51.52 37.14 18.37 17.16 34.52 29.82 11.14 Interest 10.33 6.60 17.26 20.83 9.05 6.07 4.33 2.79 2.12 2.79 3.27 Depreciation 56.61 48.86 49.61 46.55 34.82 22.28 34.96 34.01 32.78 26.66 21.19 PBT 191.79 152.98 48.54 -42.73 18.68 37.26 216.88 167.27 167.49 173.08 151.12 Tax 9.15 37.43 11.15 -8.79 7.33 25.12 44.15 37.75 34.25 41.09 35.84 Tax Rate 4.77% 34.90% 29.27% 15.08% 26.66% 27.85% 20.79% 21.76% 20.45% 24.38% 24.10% PAT 182.64 69.80 26.94 -49.48 20.16 65.09 168.19 135.75 133.24 127.45 112.86 PAT before Minority Interest 182.64 69.80 26.94 -49.48 20.16 65.09 168.19 135.75 133.24 127.45 112.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.44% 14.62% 8.70% -19.98% 5.65% 25.32% 20.87% 20.45% 17.97% 17.37% 16.70% PAT Growth 211.04% 159.09% - - -69.03% -61.30% 23.90% 1.88% 4.54% 12.93% EPS 9.34 3.57 1.38 -2.53 1.03 3.33 8.60 6.94 6.81 6.52 5.77

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,682.47 1,286.41 1,151.60 1,050.11 1,145.52 901.13 907.91 733.39 788.83 779.16 716.43 Net Sales Growth 27.91% 11.71% 9.66% -8.33% 27.12% -0.75% 23.80% -7.03% 1.24% 8.76% Cost Of Goods Sold 515.96 397.67 394.23 416.04 383.22 270.73 277.73 257.03 355.87 371.81 366.19 Gross Profit 1,166.51 888.74 757.37 634.07 762.30 630.40 630.18 476.36 432.95 407.36 350.25 GP Margin 69.33% 69.09% 65.77% 60.38% 66.55% 69.96% 69.41% 64.95% 54.89% 52.28% 48.89% Total Expenditure 1,203.92 982.48 916.10 961.84 948.32 729.43 693.40 579.39 637.60 617.55 556.44 Power & Fuel Cost - 53.74 52.41 56.79 52.43 40.25 38.76 33.57 28.86 26.30 21.90 % Of Sales - 4.18% 4.55% 5.41% 4.58% 4.47% 4.27% 4.58% 3.66% 3.38% 3.06% Employee Cost - 292.71 281.39 286.39 264.49 235.31 196.59 176.40 149.35 127.87 90.09 % Of Sales - 22.75% 24.43% 27.27% 23.09% 26.11% 21.65% 24.05% 18.93% 16.41% 12.57% Manufacturing Exp. - 122.29 95.70 110.32 120.03 89.12 79.19 61.23 59.96 52.55 45.35 % Of Sales - 9.51% 8.31% 10.51% 10.48% 9.89% 8.72% 8.35% 7.60% 6.74% 6.33% General & Admin Exp. - 59.02 43.99 46.86 71.58 47.71 70.26 27.20 22.50 16.95 14.11 % Of Sales - 4.59% 3.82% 4.46% 6.25% 5.29% 7.74% 3.71% 2.85% 2.18% 1.97% Selling & Distn. Exp. - 26.53 21.42 18.56 29.36 20.79 10.40 6.72 6.37 4.75 7.27 % Of Sales - 2.06% 1.86% 1.77% 2.56% 2.31% 1.15% 0.92% 0.81% 0.61% 1.01% Miscellaneous Exp. - 30.52 26.96 26.89 27.22 25.51 20.48 17.23 14.68 17.32 7.27 % Of Sales - 2.37% 2.34% 2.56% 2.38% 2.83% 2.26% 2.35% 1.86% 2.22% 1.61% EBITDA 478.55 303.93 235.50 88.27 197.20 171.70 214.51 154.00 151.23 161.61 159.99 EBITDA Margin 28.44% 23.63% 20.45% 8.41% 17.21% 19.05% 23.63% 21.00% 19.17% 20.74% 22.33% Other Income 7.36 36.27 17.16 31.41 20.90 40.09 22.23 15.56 32.62 29.34 11.36 Interest 52.11 75.53 91.80 58.65 41.17 21.87 4.56 3.68 2.66 3.13 3.93 Depreciation 126.00 112.99 107.87 95.50 79.80 53.98 43.78 42.06 37.22 30.64 23.14 PBT 319.96 151.68 52.99 -34.47 97.13 135.95 188.40 123.82 143.96 157.17 144.28 Tax 46.45 44.04 22.39 -7.36 41.68 48.85 33.49 26.18 33.91 42.04 35.62 Tax Rate 14.52% 35.63% 37.87% 21.35% 39.35% 24.82% 17.78% 18.22% 23.56% 27.54% 25.11% PAT 273.51 78.30 31.88 -32.48 60.66 147.78 156.15 112.26 105.24 107.57 108.34 PAT before Minority Interest 273.51 78.30 31.96 -30.92 60.58 146.20 154.56 109.50 102.86 104.45 104.74 Minority Interest 0.00 0.00 -0.08 -1.56 0.08 1.58 1.59 2.76 2.38 3.12 3.60 PAT Margin 16.26% 6.09% 2.77% -3.09% 5.30% 16.40% 17.20% 15.31% 13.34% 13.81% 15.12% PAT Growth 149.58% 145.61% - - -58.95% -5.36% 39.10% 6.67% -2.17% -0.71% EPS 13.98 4.00 1.63 -1.66 3.10 7.56 7.98 5.74 5.38 5.50 5.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,700.59 2,142.72 2,117.58 2,065.67 1,637.83 1,453.42 1,281.55 1,156.98 1,029.62 664.59 Share Capital 9.78 8.68 8.68 8.68 8.15 8.15 8.15 8.15 8.01 7.71 Total Reserves 2,690.81 2,134.04 2,108.90 2,056.99 1,629.68 1,445.27 1,273.39 1,148.83 1,021.60 656.88 Non-Current Liabilities 79.18 63.27 158.37 210.15 405.58 208.00 157.15 139.08 241.14 59.29 Secured Loans 0.00 0.00 68.00 111.37 324.52 164.48 80.39 67.08 141.18 0.00 Unsecured Loans 24.47 30.02 54.80 8.90 0.00 0.00 0.70 1.03 1.30 0.00 Long Term Provisions 3.98 3.40 0.83 5.83 13.76 8.72 5.36 5.08 5.55 4.32 Current Liabilities 226.89 212.64 242.71 161.65 473.98 359.86 229.59 251.05 219.71 205.32 Trade Payables 22.19 52.69 31.92 23.89 56.91 76.63 71.37 98.86 103.91 98.20 Other Current Liabilities 67.06 33.71 75.39 91.55 164.00 119.85 76.53 56.68 25.20 25.74 Short Term Borrowings 82.43 112.53 125.83 39.56 241.90 156.40 78.72 92.95 88.04 69.59 Short Term Provisions 55.20 13.70 9.57 6.65 11.17 6.97 2.97 2.57 2.55 11.79 Total Liabilities 3,006.66 2,418.63 2,518.66 2,437.47 2,517.39 2,021.28 1,668.29 1,547.11 1,490.47 929.20 Net Block 570.08 586.33 608.93 565.78 640.90 517.00 510.84 488.69 448.85 349.77 Gross Block 853.47 827.79 812.42 723.56 918.48 756.00 723.32 666.58 594.31 469.21 Accumulated Depreciation 283.39 241.46 203.48 157.78 277.58 238.99 212.49 177.89 145.46 119.44 Non Current Assets 2,529.38 2,041.66 1,882.41 1,692.22 1,737.50 1,113.59 1,147.87 893.90 786.14 597.17 Capital Work in Progress 281.01 228.24 226.43 293.11 482.35 372.81 401.21 200.99 136.51 89.38 Non Current Investment 1,279.50 246.45 243.92 237.50 219.32 93.48 89.04 111.35 101.78 94.05 Long Term Loans & Adv. 398.73 980.26 802.92 595.14 391.84 124.54 119.95 68.04 94.26 59.13 Other Non Current Assets 0.06 0.38 0.20 0.69 3.10 5.76 26.83 24.83 4.75 4.83 Current Assets 477.29 376.97 636.25 309.44 779.90 907.69 520.42 653.22 704.32 332.03 Current Investments 0.00 0.00 0.00 0.00 0.00 7.89 7.89 119.54 224.62 59.63 Inventories 148.58 111.92 94.50 101.77 299.08 206.23 176.70 167.72 174.96 124.66 Sundry Debtors 190.52 143.82 111.90 102.73 218.27 226.54 181.68 218.14 166.50 111.98 Cash & Bank 4.42 4.46 4.83 15.83 115.27 28.19 90.93 73.14 93.10 5.66 Other Current Assets 133.76 91.20 393.46 47.59 147.28 438.84 63.21 74.67 45.14 30.10 Short Term Loans & Adv. 72.05 25.56 31.57 41.52 106.48 78.47 45.76 58.12 31.39 27.91 Net Current Assets 250.40 164.33 393.54 147.79 305.91 547.83 290.83 402.16 484.62 126.71 Total Assets 3,006.67 2,418.63 2,518.66 2,001.66 2,517.40 2,021.28 1,668.29 1,547.12 1,490.46 929.20

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,372.24 1,808.69 1,783.28 1,822.19 1,478.67 1,329.36 1,197.58 1,085.03 986.90 639.26 Share Capital 9.78 8.68 8.68 8.68 8.15 8.15 8.15 8.15 8.01 7.71 Total Reserves 2,362.46 1,800.01 1,774.60 1,813.51 1,470.51 1,321.21 1,189.43 1,076.88 978.88 631.55 Non-Current Liabilities 259.81 589.44 345.12 452.82 561.37 256.94 166.62 153.48 251.26 67.23 Secured Loans 231.96 560.16 242.92 353.49 473.87 164.48 80.39 67.09 141.20 0.03 Unsecured Loans 0.00 0.00 45.90 0.11 0.35 0.53 0.70 1.03 1.30 0.00 Long Term Provisions 25.54 22.43 17.65 19.08 15.48 26.17 21.77 20.32 16.89 13.96 Current Liabilities 674.23 693.59 784.45 611.54 587.46 410.82 253.44 265.84 236.90 222.07 Trade Payables 95.38 174.15 142.80 146.04 76.54 92.55 80.72 103.74 111.86 106.48 Other Current Liabilities 222.13 138.05 276.56 240.13 254.21 142.10 81.62 59.59 28.03 36.49 Short Term Borrowings 306.81 360.73 344.17 202.90 243.40 165.27 86.58 98.12 92.41 74.10 Short Term Provisions 49.91 20.66 20.92 22.46 13.31 10.89 4.52 4.39 4.60 5.00 Total Liabilities 3,297.74 3,082.98 2,903.93 2,875.50 2,616.33 1,989.21 1,610.02 1,499.13 1,472.22 930.89 Net Block 1,417.84 1,384.86 1,368.33 1,341.84 1,110.53 650.44 558.01 534.20 491.93 393.41 Gross Block 2,075.99 1,946.75 1,846.68 1,727.09 1,421.10 986.42 853.16 793.24 704.89 582.20 Accumulated Depreciation 658.15 561.89 478.35 385.25 310.57 335.98 295.15 259.04 212.96 188.79 Non Current Assets 2,312.07 2,206.74 2,134.37 1,988.30 1,729.60 1,365.35 1,064.96 827.16 742.33 576.68 Capital Work in Progress 821.77 718.78 655.33 506.18 541.29 666.25 429.12 209.85 140.51 91.90 Non Current Investment 34.54 39.91 42.66 34.23 21.22 10.45 2.25 20.79 27.99 34.15 Long Term Loans & Adv. 36.55 53.32 56.53 93.90 43.10 32.42 48.75 37.47 77.09 52.39 Other Non Current Assets 1.37 9.87 11.52 12.15 13.46 5.78 26.84 24.86 4.80 4.83 Current Assets 985.67 876.24 769.55 887.19 862.47 623.85 545.06 671.97 729.88 354.21 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 119.54 224.62 59.63 Inventories 347.93 344.93 319.82 355.24 333.19 226.43 187.67 188.71 190.00 134.23 Sundry Debtors 440.84 392.05 324.35 386.33 233.54 246.79 203.73 220.27 170.93 125.43 Cash & Bank 28.52 31.77 21.56 34.11 123.60 44.56 94.54 73.83 100.39 11.03 Other Current Assets 168.38 16.28 15.53 9.36 172.14 106.06 59.13 69.62 43.94 23.90 Short Term Loans & Adv. 150.79 91.22 88.29 102.16 146.24 95.97 47.99 56.59 31.61 21.18 Net Current Assets 311.44 182.65 -14.89 275.66 275.01 213.04 291.62 406.13 492.98 132.14 Total Assets 3,297.74 3,082.98 2,903.92 2,875.49 2,592.07 1,989.20 1,610.02 1,499.13 1,472.21 930.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -19.06 9.55 2.08 173.87 69.63 129.79 164.16 54.46 50.49 119.65 PBT 107.24 38.09 12.68 192.89 255.54 233.99 155.60 167.49 168.53 148.70 Adjustment 7.25 17.13 -35.56 32.64 -25.46 -5.39 25.78 8.68 15.28 18.05 Changes in Working Capital -116.18 -38.72 33.37 -17.17 -117.10 -57.95 18.23 -81.25 -99.93 -15.54 Cash after chg. in Working capital -1.69 16.50 10.49 208.36 112.97 170.65 199.61 94.92 83.89 151.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.37 -6.95 -8.41 -34.49 -43.34 -40.85 -35.45 -40.45 -33.40 -31.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -433.29 155.82 -94.83 -378.97 -238.13 -295.10 -214.71 -12.83 -274.78 -100.98 Net Fixed Assets -78.45 -17.18 -22.18 384.16 -272.02 -4.28 -256.96 -136.75 -172.23 -92.14 Net Investments -1,033.05 -2.53 -6.42 -18.18 -117.95 -4.44 133.96 95.51 -172.72 -14.09 Others 678.21 175.53 -66.23 -744.95 151.84 -286.38 -91.71 28.41 70.17 5.25 Cash from Financing Activity 450.09 -163.07 87.68 97.23 255.58 170.10 8.17 -61.16 315.27 -14.58 Net Cash Inflow / Outflow -2.26 2.30 -5.07 -107.88 87.08 4.80 -42.38 -19.53 90.98 4.09 Opening Cash & Equivalents 4.46 2.49 7.42 115.01 27.94 30.53 73.14 92.68 1.70 -3.02 Closing Cash & Equivalent 4.42 4.46 2.35 7.13 115.01 27.94 30.76 73.14 92.68 1.07

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 132.18 136.67 179.92 105.13 46.93 124.38 146.78 44.92 37.48 128.70 PBT 122.33 54.34 -38.28 102.26 196.79 188.40 143.70 136.77 146.49 140.36 Adjustment 195.04 221.44 147.81 109.34 4.03 41.32 20.44 18.83 17.19 20.61 Changes in Working Capital -138.18 -97.92 102.77 -71.99 -106.29 -63.15 18.71 -69.66 -92.61 -2.70 Cash after chg. in Working capital 179.20 177.86 212.30 139.62 94.53 166.57 182.85 85.94 71.08 158.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -47.02 -41.19 -32.37 -34.48 -47.60 -42.20 -36.07 -41.02 -33.60 -29.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -199.08 -166.58 -232.61 -285.50 -404.28 -289.52 -196.16 -8.76 -262.23 -109.20 Net Fixed Assets -78.45 -17.18 -22.18 384.16 -272.02 -4.28 -256.96 -136.75 -172.23 -92.14 Net Investments -1,033.05 -2.53 -6.42 -18.18 -117.95 -4.44 133.96 95.51 -172.72 -14.09 Others 912.42 -146.87 -204.01 -651.48 -14.31 -280.80 -73.16 32.48 82.72 -2.97 Cash from Financing Activity 62.65 46.77 45.80 82.86 436.37 175.50 10.06 -60.91 312.70 -19.65 Net Cash Inflow / Outflow -4.25 16.86 -6.89 -97.51 79.03 10.36 -39.32 -24.75 87.95 -0.15 Opening Cash & Equivalents 31.76 19.07 25.62 122.85 44.31 34.13 73.83 99.97 7.05 3.61 Closing Cash & Equivalent 28.52 31.76 19.07 25.34 123.34 44.31 34.36 73.83 99.97 6.43

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 138.08 123.43 243.96 237.97 200.89 178.27 157.19 141.91 128.50 86.20 ROA 2.57% 1.09% -1.83% 0.74% 2.87% 10.50% 7.72% 8.77% 10.53% 13.19% ROE 2.88% 1.26% -2.37% 1.09% 4.21% 14.17% 10.18% 12.19% 15.05% 18.39% ROCE 4.47% 2.36% -1.61% 1.61% 4.67% 14.44% 11.27% 13.00% 16.98% 21.70% Fixed Asset Turnover 0.57 0.38 0.32 0.43 0.31 1.09 0.96 1.18 1.39 1.61 Receivable days 127.83 150.65 158.13 164.12 315.80 92.44 109.91 94.36 68.87 48.77 Inventory Days 99.59 121.60 144.60 204.94 358.76 86.71 94.68 84.06 74.10 65.76 Payable days 123.03 194.46 139.04 218.12 479.17 46.77 62.82 63.90 61.73 57.90 Cash Conversion Cycle 104.39 77.79 163.69 150.94 195.39 132.38 141.78 114.52 81.24 56.63 Total Debt/Equity 0.04 0.07 0.14 0.09 0.40 0.26 0.15 0.16 0.23 0.13 Interest Cover 17.24 3.21 -1.80 4.04 15.85 55.05 56.69 79.92 61.31 46.45

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 121.29 104.19 205.44 209.93 181.37 163.06 146.89 133.09 123.17 82.91 ROA 2.45% 1.07% -1.07% 2.20% 6.33% 8.61% 7.56% 7.41% 9.20% 11.58% ROE 3.75% 1.78% -1.71% 3.67% 10.41% 12.26% 10.30% 10.62% 13.60% 17.92% ROCE 6.94% 5.49% 0.80% 5.94% 10.73% 12.41% 11.05% 11.71% 15.91% 19.90% Fixed Asset Turnover 0.64 0.61 0.59 0.73 0.75 0.99 0.89 1.06 1.22 1.36 Receivable days 118.16 113.53 123.51 98.75 94.03 90.56 105.51 90.20 69.00 52.26 Inventory Days 98.29 105.35 117.32 109.68 110.03 83.24 93.66 87.32 75.49 66.97 Payable days 123.69 146.72 126.70 106.00 107.72 47.69 58.00 61.51 60.89 60.10 Cash Conversion Cycle 92.76 72.15 114.12 102.43 96.33 126.11 141.17 116.00 83.61 59.13 Total Debt/Equity 0.25 0.52 0.45 0.37 0.57 0.29 0.16 0.18 0.24 0.14 Interest Cover 2.62 1.59 0.35 3.48 9.92 42.34 40.09 55.10 49.69 37.07

Top Investors:

suraj kumar inani

sbi life insurance co. ltd

sunidhi capital private limited

cohesion mk best ideas sub-trust

amal parikh

dovetail india fund class 5 shares

bandhan healthcare fund

elm park fund limited

icici prudential elss tax saver fund

sapphire intrex limited

Annual Reports:

News Update:

Shilpa Medicare - Quarterly Results
6th Aug 2026, 00:00 AM

Read More
Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility
24th Jun 2026, 09:58 AM

This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing
Read More
Shilpa Medicare’s arm enters into strategic equity partnership with Gate2Brain
3rd Jun 2026, 12:00 PM

G2B-002 delivers SN-38, a potent anticancer agent, across the blood-brain barrier via Gate2Brain's proprietary MiniAp4 peptide shuttle
Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: